BCTXW
BriaCell Therapeutics Corp.
NASDAQ · Healthcare · Biotechnology · CA
$0.00
−0.00%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-109.4%
Return on equity
-100.7%
Return on assets
-95.7%
Return on invested capital
0.00x
Asset turnover
-$26.2M
Cash from operations
$15
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Apr 1, 2026